A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.

NCT06719219 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcus (S.) Aureus Infection

Interventions

BIOLOGICAL: LTB-SA7
BIOLOGICAL: Placebo

Sponsor

LimmaTech Biologics AG

Collaborators

[object Object]
[object Object]
[object Object]